Document is current
Any future updates will be listed below
-
Authors
Rades, Dirk
Narvaez-Wolf, Carlos Andres
Dziggel, Liesa
Staackmann, Christian
Radtke, Maike
Timke, Carmen
Kristiansen, Charlotte
Duma, Marciana-Nona
Yu, Nathan Y.
Janssen, Stefan
-
Funding
Funding for this research was provided by:
Interreg (01-1-23 2)
Universität zu Lübeck
- License Information
-
More Information
Article History
Received: 22 July 2024
Accepted: 10 March 2025
First Online: 20 March 2025
Declarations
:
: The study was approved by the ethics committee of the University of Lübeck (reference: 2024-281). It is conducted in accordance with the principles of the Declaration of Helsinki and GCP. Patients are included after they have given written informed consent.
: Not applicable.
: Dirk Rades is member of the editorial boards of BMC Cancer and BMC Neurology, and Stefan Janssen is member of the editorial board of BMC Cancer. Otherwise, the authors declare no competing interests related to the DAI-BREAC trial.
